Speaker: Elena Ratner, M.D.: Dr. Ratner is a Board Certified Gynecologic oncologist with special interests in chemotherapy targeted drug development, patient quality of life programs and early cancer detection. Her credentials include: Associate Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale New Haven School of Medicine; Co-Chief, Section of Gynecologic Oncology, Director and Founder of Sexuality & Intimacy in Menopause Program, and Director of Discovery To Cure, at Yale New Haven Health Cancer Center, Smilow Cancer Hospital; Director of Early Ovarian Cancer Detection Program, Director of Gynecologic Oncology, at Stamford Health.
As a gynecologic oncologist, Dr. Elena Ratner partners with women throughout their cancer journey, delivering comprehensive, personalized care. Dr. Ratner helps her patients experience a high quality of life throughout treatment and into survivorship by fitting treatment around their lives and providing targeted therapies with as few side effects as possible. She works hard with each patient to preserve a sense of normalcy and to prevent cancer from taking over their lives. As the founder of the Sexuality & Intimacy in Menopause Program, she helps survivors of cancer reconnect with their bodies using a multidisciplinary approach, including counseling, hormone therapy and other techniques.
Dr. Ratner practices bench-to-bedside research, examining her patient’s tumors and identifying their specific types of cancer. This allows her to design an effective, individualized treatment plan for each patient. In her lab, she also works to develop new chemotherapy and cancer drugs that effectively treat cancer and improve quality of life for her patients. As a result of her commitment to gynecologic cancer care, Dr. Ratner has received many awards for her teaching, research and patient care. Most recently, she was given the Yale University Smilow Cancer Center Award for Clinical Excellence.
- The newest info on the development of drugs for advanced ovarian cancer
- The role of personalized medicine
- Targeted therapies
- PARP Inhibitors
- Quality of life issues
- Sexuality and menopause
- Question and answer period
Audio and slides from Support Connection’s Webinar “Updates in Treatment for Ovarian Cancer” – Recorded on Sept. 24, 2019